NCT01037023View on ClinicalTrials.gov

Regulatory Hycamtin(Oral) PMS

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Lung Cancer, Small Cell
Interventions
DRUG

Topotecan

patients administrated Topotecan according to the prescribing information

Trial Locations (2)

463-707

GSK Investigational Site, Seongnam-si, Gyeonggi-do

137-701

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01037023 - Regulatory Hycamtin(Oral) PMS | Biotech Hunter | Biotech Hunter